English | 繁體

Search in the results

UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Atezolizumab plus platinum-based chemotherapy as first-line therapy for metastatic urothelial cancer: A cost-effectiveness analysis Journal article
Liu, Xiaoyan, Lang, Yitian, Chai, Qingqing, Lin, Yan, Liao, Yahui, Zhu, Yizhun. Atezolizumab plus platinum-based chemotherapy as first-line therapy for metastatic urothelial cancer: A cost-effectiveness analysis[J]. Frontiers in Pharmacology, 2022, 13.
Authors:  Liu, Xiaoyan;  Lang, Yitian;  Chai, Qingqing;  Lin, Yan;  Liao, Yahui; et al.
Favorite | TC[WOS]:4 TC[Scopus]:4  IF:4.4/5.0 | Submit date：2023/01/30
Atezolizumab  Cost-effectiveness  Metastatic Urothelial Cancer  Partitioned Survival Model  The Perspective Of The United States And China  
Corin plays a protective role via upregulating MAPK and downregulating eNOS in diabetic nephropathy endothelial dysfunction Journal article
Xue,Meiting, Shi,Yue, Pang,Aiming, Men,Li, Hu,Yahui, Zhou,Pengfei, Long,Guangfeng, Tian,Xin, Wang,Rong, Zhao,Yonghua, Liao,Xudong, Shen,Yanna, Cui,Yujie. Corin plays a protective role via upregulating MAPK and downregulating eNOS in diabetic nephropathy endothelial dysfunction[J]. FASEB JOURNAL, 2019, 34(1), 95-106.
Authors:  Xue,Meiting;  Shi,Yue;  Pang,Aiming;  Men,Li;  Hu,Yahui; et al.
Favorite | TC[WOS]:11 TC[Scopus]:11  IF:4.4/4.7 | Submit date：2021/03/02
Corin  Diabetic Nephropathy  Endothelial Dysfunction  Enos  Mapk